⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
DNA Diagnostics Research Report 2026 - Global Market Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031
globenewswire.com
ILMN
GH
SOPH
Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
businesswire.com
GH
Plug and Play Turns 20: New Book Tells the Story of the Global Innovation Powerhouse
prnewswire.com
GOOGL
PYPL
LC
DBX
SOUN
GH
Oncology Information System Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire.com
GH
Whole Genome and Exome Sequencing: Global Market Review 2021-2025 and Growth Outlook 2026-2031 Featuring Illumina, Thermo Fisher Scientific, BGI Genomics and Other Leading Players
globenewswire.com
ILMN
TMO
PACB
GH
REGN
DNA Methylation Detection Technology Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire.com
EXAS
GH
TEMP
Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More
globenewswire.com
TMO
GH
EXAS
TEMP
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
businesswire.com
GH
MARQUE CE POUR LA NOUVELLE GAMME DE DIAMÈTRES DE L'ENDOPROTHÈSE GORE® VIATORR® TIPS À EXPANSION CONTRÔLÉE USA - Français Middle East - Arabic USA - español USA - English USA - Deutsch
prnewswire.com
GH
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
businesswire.com
GH